发明名称 |
Resazurin-based cytotoxicity assay |
摘要 |
The method of the present invention relies on culturing hepatic cells in a growth medium in the presence of resazurin and a cytotoxic compound for a period time, and then measuring the degree of fluorescence of reduced resazurin as an indicator of nonviable cells. The assays described herein are particularly useful in screening drugs to determine their cytotoxic potential. Most commonly, drugs would be screened by the methods described herein to determine their potential hepatic toxicity as an alternative to current in vitro or in vivo models of liver toxicity. Alternatively the methods described herein could be used to determine the chemotherapeutic efficacy of drugs, particularly those directed towards hepatic tumors. |
申请公布号 |
AU6826401(A) |
申请公布日期 |
2002.01.02 |
申请号 |
AU20010068264 |
申请日期 |
2001.06.08 |
申请人 |
ORTHO-MCNEIL PHARMACEUTICAL, INC. |
发明人 |
MICHAEL MCMILLIAN;ZHONG ZHONG;MARK JOHNSON;LEKHA PATEL |
分类号 |
G01N33/50 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|